Utah SB0222 expands access to investigational drugs by removing the terminal illness requirement and broadening the definition of eligible illnesses.

Utah SB0222, known as the Right to Try Amendments, modifies the state's access to investigational drugs and devices. It removes the requirement that patients must have a terminal illness to access these treatments. Instead, it allows patients diagnosed with an "eligible illness" to obtain investigational drugs. The bill also updates the definition of "eligible illness" to include conditions that pose a significant risk to the patient compared to conventional treatments. Additionally, it amends the definition of "medicinal dosage form" to include various forms of medication.

Utah SB0222 expands access to investigational drugs by removing the terminal illness requirement and broadening the definition of eligible illnesses.

Utah SB0222, known as the Right to Try Amendments, modifies the state's access to investigational drugs and devices. It removes the requirement that patients must have a terminal illness to access these treatments. Instead, it allows patients diagnosed with an "eligible illness" to obtain investigational drugs. The bill also updates the definition of "eligible illness" to include conditions that pose a significant risk to the patient compared to conventional treatments. Additionally, it amends the definition of "medicinal dosage form" to include various forms of medication.